N/A N=55 Randomized Single-blind Prevention

Eating Disorder Prevention Program for Women With T1D

Eating Disorders · Type 1 Diabetes

Bottom Line

View on ClinicalTrials.gov: NCT05264376 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2025

Primary outcome: Primary: Percentage of Time With Blood Sugar in Range as a Measure of Glycemic Control — 0.61; 0.63 percentage of time

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Diabetes Body Project (Behavioral); Educational Control (Behavioral)
Age: Pediatric, Adult · 15+ yrs
Sex: Female
Sponsor: Stanford University
Primary completion: Apr 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Time With Blood Sugar in Range as a Measure of Glycemic Control	0.61; 0.63	—
PRIMARY Eating Disorder Symptoms	6.50; 11.87; 5.82; 12.30	—
PRIMARY Body Dissatisfaction (BS)	2.98; 3.46; 3.09; 3.29	—
PRIMARY Thin Ideal Internalization	2.92; 3.15; 3.12; 3.10	—
PRIMARY Diabetes-Specific Eating Pathology	0.64; 1.02; 0.70; 1.06	—
PRIMARY Diabetes-Specific Distress	1.81; 2.08; 1.92; 2.18	—
PRIMARY Negative Affect	1.79; 2.01; 1.95; 2.34	—
PRIMARY Quality of Life (Well-Being)	2.94; 2.55; 2.75; 2.17	—

Summary

This study aims to test the effectiveness of an evidence-based eating- disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.

Eligibility Criteria

Inclusion Criteria

I)female-identifying II) aged 15-30 years old III) diagnosis of T1D for at least a 6-month duration per American Diabetes Association(ADA) criteria who are taking insulin IV) have visited their diabetes care provider in the past year V) body image concerns

Exclusion Criteria

I) not female identifying II) not in age range III) does not have a diagnosis of T1D for at least 6 months per ADA criteria who are taking insulin IV) have not visited their diabetes care provider in the past year V) do not report some level of body dissatisfaction

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05264376). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.